A1c-Cellular from Streck, Omaha, Ne, the first whole red blood cell A1c control on the market with intact red blood cells, is now assayed for the Abbott Architect Integrated ci instruments. A1c-Cellular tests the entire HbA1c procedure, including the lysing of the red blood cell, a step often omitted with other controls. A1c-Cellular is also assayed for the Abbott Architect c systems; Arkray Menarini Adams A1c HA-8160; Beckman Coulter UniCel DxC 600/800; Bio-Rad D-10/Variant II and Variant II Turbo; Vitros 5,1 FS/5600; Cobas Integra/6000/c311; Siemens Dimension series; and Tosoh A1c 2.2 Plus, G7/G8. The control does not need to be reconstituted, and offers closed-vial stability of 6 months and open-vial stability of 30 days when stored at 2°C to 10°C. For more information, visit Streck.
Streck Adds Abbott Instrument to A1c Control Assay
